SOMOS

SOMOS

Crowdsourcing the Latino Genome to accelerate drug discovery

Print
Claim My Business View on Republic
Security Type
Crowd SAFE
Min Investment
$100
Location
SAN FRANCISCO, CA
Offering Date
May 16, 2022
Expected Close Date
October 09, 2022
Amount Raised
$31,734
Target Raise
$25K-$1M
No. Investors
54
Security Price
$1
Number of Employees
0
Cash
$498,755
Revenue
$196,306
Short Term Debt
$421,368
Cost of Goods
$25,441
Long Term Debt
$0
Net Income
$-40,956

Company Description

We are building the world's largest Pan-American biobank, called "Familia", through unique datasets and ancestral DNA sequencing. Just during phase 1 in México, our biobank will create a genetic repository 100x larger than what's currently available for research.

Perks

Reserve
$500
Receive
Special Edition SOMOS Bracelet "IWAMA"- by wixárika artists from México
Limited (100 left of 100)

2 reservations
Reserve
$1,000
Receive
Special Edition SOMOS Bracelet "IWAMA"- by wixárika artists from México
50% discount in SOMOS DNA kit
Special SOMOS digital badge designed by Mexican Artist Javier Gonzalez
Limited (198 left of 200)

1 reservation
Reserve
$5,000
Receive
Special Edition SOMOS Bracelet "IWAMA"- by wixárika artists from México
50% discount on SOMOS DNA kit
Limited Edition SOMOS digital badge designed by Mexican Artist Javier Gonzalez
Limited edition DNA Kit box designed by Javier Gonzalez with Olinalá traditional art (included when purchasing DNA kit)
Limited (299 left of 300)

Reserve
$10,000
Receive
Special Edition SOMOS Bracelet "IWAMA"- by wixárika artists from México
Free SOMOS DNA kit
Limited Edition SOMOS digital badge designed by Mexican Artist Javier Gonzalez
Limited edition DNA Kit box designed by Javier Gonzalez with Olinalá traditional art
(when buying the kit)
1 Pair - Handcrafted Shoes made in Nahua region of Tepoztlán
Limited (100 left of 100)

Reserve
$25,000
Receive
Special Edition SOMOS Bracelet "IWAMA"- by wixárika artists from México
1 Special Edition SOMOS T-Shirt - by Javier Gonzalez
1 Free SOMOS DNA kit
Limited Edition SOMOS digital badge designed by Mexican Artist Javier Gonzalez
Limited edition DNA Kit box designed by Javier Gonzalez with Olinalá traditional art
1 Pair - Handcrafted Shoes made in Nahua region of Tepoztlán
Limited (50 left of 50)

Reserve
$50,000
Receive
2 Special Edition SOMOS Bracelet "IWAMA"- by wixárika artists from México
2 Special Edition SOMOS T-Shirt - by Javier Gonzalez
2 Free DNA Test Kit, with DNA Kit box designed by Javier Gonzalez
SOMOS digital collectible NFT designed by Mexican Artist Javier Gonzalez (limited to 50 Tokens)
2 Pairs - Handcrafted Shoes made in Nahua region of Tepoztlán
Meet the Founders in Riviera Maya, visit the Mayan ruins, Mayan Xibalba-Underworld Cenotes (flight and hotel not included)
Limited (25 left of 25)

Reserve
$100,000
Receive
2 Special Edition SOMOS Bracelet "IWAMA"- by wixárika artists from México 2 Special Edition SOMOS T-Shirt - by Javier Gonzalez 2 Free DNA Test Kit, with DNA Kit box designed by Javier Gonzalez
SOMOS digital collectible NFT designed by Mexican Artist Javier Gonzalez (limited to 50 Tokens)
2 Pairs - Handcrafted Shoes made in Nahua region of Tepoztlán
Meet the Founders in Riviera Maya, visit Mayan ruins, Cenotes (flight and hotel not included) & Cooking masterclass with local chef
Limited (10 left of 10)

Key Deal Facts

Accelerating drug discovery for Latinos/Hispanics/ Native Americans
Crowdsourcing the Latino GENOME
Avoiding digital colonialism, decentralizing biological data using Bio NFTs
23&me for Latinos with social impact in Indigenous Communities
Revenue of $226k+ in 18 months, 4,700+ paid users
Focus on $3.4B DTC genetics market, expanding to the $63B+ pharma in LatAm
Seasoned MDs with 5+ years in genomics and Latino markets

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments